(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of 1.5% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Dentsply Sirona's revenue in 2026 is $3,643,000,000.On average, 20 Wall Street analysts forecast XRAY's revenue for 2026 to be $728,040,355,152, with the lowest XRAY revenue forecast at $692,754,719,100, and the highest XRAY revenue forecast at $756,348,605,544. On average, 20 Wall Street analysts forecast XRAY's revenue for 2027 to be $742,991,895,852, with the lowest XRAY revenue forecast at $702,523,059,024, and the highest XRAY revenue forecast at $775,287,223,764.
In 2028, XRAY is forecast to generate $759,936,975,312 in revenue, with the lowest revenue forecast at $716,677,184,220 and the highest revenue forecast at $803,595,474,156.